Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Jackson

Showing results (171-180 of 203) with videos related to

Pageof 21
Sort By:
Neurosurgical Focus|September 1, 2025
Impact of preoperative medical management on postoperative outcomes after index percutaneous rhizotomy for trigeminal neuralgiaMegan Parker, Yuanxuan Xia, Melanie Alfonzo Horowitz, et al.
Molecular Diagnosis & Therapy|April 26, 2023
Dynamic ctDNA Mutational Complexity in Patients with Melanoma Receiving ImmunotherapySandra Fitzgerald, Cherie Blenkiron, Rosalie Stephens, et al.
Oncoimmunology|September 6, 2021
Combination checkpoint therapy with anti-PD-1 and anti-BTLA results in a synergistic therapeutic effect against murine glioblastomaJohn Choi, Ravi Medikonda, Laura Saleh, et al.
Journal of General Internal Medicine|November 30, 2021
Primary Care Practice Transformation in the Era of COVID-19 and Beyond: Key Principles for General Internal Medicine PractitionersStacie Schmidt, Reena Gupta, Jennifer Bracey, et al.
JCO Oncology Practice|May 14, 2020
Practical Considerations for Treating Patients With Cancer in the COVID-19 PandemicEva Segelov, Craig Underhill, Hans Prenen, et al.
Cancer Letters|March 15, 2025
Pre-treatment DNA methylome and transcriptome profiles correlate with melanoma response to anti-PD1 immunotherapySultana Mehbuba Hossain, Gregory Gimenez, Peter Stockwell, et al.
International Journal of Cancer|May 1, 2021
The impact of reclassifying cancers of unspecified histology on international differences in survival for small cell and non-small cell lung cancer (ICBP SurvMark-2 project)Eileen Morgan, Melina Arnold, Mark J Rutherford, et al.
Journal of Neuro-Oncology|June 16, 2025
Patient nutritional status is associated with surgical site infections in meningioma patients undergoing craniotomy for tumor resectionSachiv Chakravarti, Linda Tang, Harshal A Shah, et al.
BMC Cancer|August 5, 2018
Barrett's oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid refluxJudith Offman, Beth Muldrew, Maria O'Donovan, et al.
Journal of Neuro-Oncology|October 26, 2012
The role of STAT3 activation in modulating the immune microenvironment of GBMAlfred P See, James E Han, Jillian Phallen, et al.
Pageof 21

Showing results (171-180 of 203) with videos related to

Sort By:
Pageof 21
Neurosurgical Focus|September 1, 2025
Impact of preoperative medical management on postoperative outcomes after index percutaneous rhizotomy for trigeminal neuralgiaMegan Parker, Yuanxuan Xia, Melanie Alfonzo Horowitz, et al.
Molecular Diagnosis & Therapy|April 26, 2023
Dynamic ctDNA Mutational Complexity in Patients with Melanoma Receiving ImmunotherapySandra Fitzgerald, Cherie Blenkiron, Rosalie Stephens, et al.
Oncoimmunology|September 6, 2021
Combination checkpoint therapy with anti-PD-1 and anti-BTLA results in a synergistic therapeutic effect against murine glioblastomaJohn Choi, Ravi Medikonda, Laura Saleh, et al.
Journal of General Internal Medicine|November 30, 2021
Primary Care Practice Transformation in the Era of COVID-19 and Beyond: Key Principles for General Internal Medicine PractitionersStacie Schmidt, Reena Gupta, Jennifer Bracey, et al.
JCO Oncology Practice|May 14, 2020
Practical Considerations for Treating Patients With Cancer in the COVID-19 PandemicEva Segelov, Craig Underhill, Hans Prenen, et al.
Cancer Letters|March 15, 2025
Pre-treatment DNA methylome and transcriptome profiles correlate with melanoma response to anti-PD1 immunotherapySultana Mehbuba Hossain, Gregory Gimenez, Peter Stockwell, et al.
International Journal of Cancer|May 1, 2021
The impact of reclassifying cancers of unspecified histology on international differences in survival for small cell and non-small cell lung cancer (ICBP SurvMark-2 project)Eileen Morgan, Melina Arnold, Mark J Rutherford, et al.
Journal of Neuro-Oncology|June 16, 2025
Patient nutritional status is associated with surgical site infections in meningioma patients undergoing craniotomy for tumor resectionSachiv Chakravarti, Linda Tang, Harshal A Shah, et al.
BMC Cancer|August 5, 2018
Barrett's oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid refluxJudith Offman, Beth Muldrew, Maria O'Donovan, et al.
Journal of Neuro-Oncology|October 26, 2012
The role of STAT3 activation in modulating the immune microenvironment of GBMAlfred P See, James E Han, Jillian Phallen, et al.
Pageof 21